Medical doctor, specialized in tropical medicine, emergency medicine and epidemiology. In 1989 he went on mission with Médecins sans Frontières for the first time, and undertook long-term missions in Uganda, Somalia and Thailand. He returned to the Paris headquarters in 1994 as a programs director. Between 1996 and 1998, he served as the director of communications, and later as director of operations until May 2000 when he was elected president of the French section of Médecins sans Frontières. He was re-elected in May 2003 and in May 2006. From 2000 to 2008, he was a member of the International Council of MSF and a member of the Board of MSF USA. He is the co-editor of "Medical innovations in humanitarian situations" (MSF, 2009) and Humanitarian Aid, Genocide and Mass Killings: Médecins Sans Frontiéres, The Rwandan Experience, 1982–97 (Manchester University Press, 2017).
To address the political, economic and legal barriers to patients' access to life-saving treatments, MSF created, in 1999, the Access Campaign (the Campaign for Access to Essential Medicines). In these videos, Jean-Hervé Bradol, doctor and crash study director, answers questions from Andrea Bussotti (MSF-France Operational Communication Manager). In the light of the historical background of the early days of the Access Campaign, he analyses the medico-operational context of the Campaign today and asks himself the question of its objectives.
Table of contents
Part 1 The circumstances of the creation of the MSF Access Campaign: the powerless doctor
Part 2 Explaining the shortage of medicines in poor countries
Part 3 The early days of the Access Campaign
Part 4 The decline in drug prices: A Combination of Factors
Part 5 The evolution of global health parameters from the 2000s to present
Part 6 What is the fair price of a drug?
Part 7 The Access Campaign today
Part 8 Campaign Effectiveness: Inequalities (example of cancer) and transgressions
Part 9 Transparency of drug prices, free movement and health insurance